Cargando…
Meta-Analysis Reveals Significant Sex Differences in Chronic Lymphocytic Leukemia Progression in the Eµ-TCL1 Transgenic Mouse Model
The Eµ-TCL1 transgenic mouse model represents the most widely and extensively used animal model for chronic lymphocytic leukemia (CLL). In this report, we performed a meta-analysis of leukemia progression in over 300 individual Eµ-TCL1 transgenic mice and discovered a significantly accelerated disea...
Autores principales: | Koch, Maximilian, Reinartz, Sebastian, Saggau, Julia, Knittel, Gero, Rosen, Natascha, Fedorchenko, Oleg, Thelen, Lisa, Barthel, Romy, Reinart, Nina, Seeger-Nukpezah, Tamina, Reinhardt, Hans Christian, Hallek, Michael, Nguyen, Phuong-Hien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409315/ https://www.ncbi.nlm.nih.gov/pubmed/32698538 http://dx.doi.org/10.3390/cancers12071980 |
Ejemplares similares
-
IDO1-Targeted Therapy Does Not Control Disease Development in the Eµ-TCL1 Mouse Model of Chronic Lymphocytic Leukemia
por: Öztürk, Selcen, et al.
Publicado: (2021) -
The Tumor Microenvironment-Dependent Transcription Factors AHR and HIF-1α Are Dispensable for Leukemogenesis in the Eµ-TCL1 Mouse Model of Chronic Lymphocytic Leukemia
por: Gonder, Susanne, et al.
Publicado: (2021) -
The scaffold protein NEDD9 is necessary for leukemia-cell migration and disease progression in a mouse model of chronic lymphocytic leukemia
por: Rusyn, Lisa, et al.
Publicado: (2022) -
Anti-apoptotic A1 is not essential for lymphoma development in Eµ-Myc mice but helps sustain transplanted Eµ-Myc tumour cells
por: Mensink, Mark, et al.
Publicado: (2018) -
Macrophage-Mediated Antibody Dependent Effector Function in Aggressive B-Cell Lymphoma Treatment is Enhanced by Ibrutinib via Inhibition of JAK2
por: Barbarino, Verena, et al.
Publicado: (2020)